Earnings Call Insights: Teva Pharmaceutical Industries Limited (TEVA) Q1 2025
Management View
- CEO Richard Francis highlighted that Q1 2025 marks the ninth consecutive quarter of growth for Teva, underscoring the success of its “Pivot to Growth” strategy launched in 2023. Revenue grew 5% to $3.9 billion, with